GlassScriptPhysician profile
Oscar Osorio
NPI 1346245644
$2,322.60
in general payments reported to CMS, 2019-2025
13 companies · $70.67 in 2025
The $70.67 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $270 · 2021: $1,519 · 2022: $209 · 2024: $55.00 · 2025: $70.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,631.88 | 2020-2021 | |
| Astellas Pharma US INC | $159.99 | 2019-2022 | |
| Abbvie INC. | $131.96 | 2019-2021 | |
| Abbott Laboratories | $83.84 | 2022 | |
| Minerva Surgical, INC | $70.67 | 2025 | |
| Nevro Corp. | $44.55 | 2020 | |
| Millicent US INC | $40.05 | 2022 | |
| Bioventus LLC | $38.30 | 2019 | |
| Covidien LP | $33.92 | 2020 | |
| Hologic Sales and Service, LLC | $30.00 | 2024 | Aptima |
| Merck Sharp & Dohme LLC | $25.00 | 2024 | Gardasil 9, Gardasil |
| Acelrx Pharmaceuticals, INC. | $17.14 | 2019 | |
| Medtronic, INC. | $15.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Osorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.